This file is provided for reference purposes only. It was current when it was produced, but it is no longer maintained and may now be out of date. Persons with disabilities having difficulty accessing information may
contact us for assistance. For reliable, current information on this and other health topics, we recommend consulting the NIH Clinical Center at
http://www.cc.nih.gov/.
|
Prostate
Cancer
Dr. William Dahut
Head, Prostate Cancer Clinic
National Cancer Institute
|
Tuesday,
Oct. 24, 2000 7 pm
Masur AuditoriumNIH Clinical Center
|
|
 |
An expert on prostate cancer,
Dr. William Dahut heads the Prostate Cancer Clinic of the National Cancer Institute.
He received his undergraduate and medical degrees from Georgetown University
in Washington, D.C. He then completed his internship in internal medicine at
the Naval Hospital in Portsmouth, Virginia. He continued his training with a
residency in internal medicine at the National Naval Medical Center in Bethesda,
Maryland. This was followed by an NCI fellowship in hematology/ oncology with
the Navy Medical Oncology Branch.
He holds certification by
the American Board of Internal Medicine in the subspecialties of medical oncology
and hematology, and licensure in Maryland and the District of Columbia. Dr.
Dahut has varied medical experience, including work as an attending physician
on the emergency medicine staff of the Naval Hospital at Camp Lejeune, North
Carolina, and as a hematologist/oncologist with the National Naval Medical Center.
Until 1999, Dr. Dahut served as assistant professor of medicine in the Department
of Medicine at Georgetown University, where he also was a member of its institutional
review board.
He has worked actively with
the Lombardi Cancer Center, both as a hematologist/ oncologist and as a member
of its clinical research committee. Previous academic appointments were with
the Uniformed Services University of the Health Sciences. Dr. Dahut has held
membership in a number of professional societies, such as the American Society
of Clinical Oncology, the American Association for Cancer Researchers, and the
American College of Physicians. He has reviewed submissions to leading medical
journals including Cancer Research, Clinical Center Research, and Contemporary
Oncology. Dr. Dahut 's primary research interest has been the development of
new treatments for adenocarcinoma of the prostate.
Medicine
for the Public home

The information on this page is archived and provided for reference purposes only.